>>> there’s no provision that revokes the EUA when alternatives emerge.
Funny how we have not heard any complaints from Maderna, J&J, others about their seemingly unequal treatment or lack of consideration for their “full approval” as well.
Not funny at all. They submitted their respective applications and paperwork to the FDA later than Pfizer did and they know it.
Don’t worry. Both will get BLAs.